ライフサイエンスコーパス: postpartum

1 ed breast-milk samples at both 2 wk and 2 mo postpartum).

2 d were receiving ART] were followed to 12 mo postpartum.

3 in the third trimester and at least 2 weeks postpartum.

4 monitor maternal aminotransferase elevations postpartum.

5 disease in women pregnant or within 42 days postpartum.

6 (+/-4) weeks of pregnancy and 8 (+/-4) weeks postpartum.

7 age 30+6, LVEF 0.34+0.10 at entry 31+25 days postpartum.

8 fancy or the likelihood of stunting at 12 mo postpartum.

9 life events were ascertained prenatally and postpartum.

10 : no HS (control) group or HS from 0 to 5 mo postpartum.

11 dently affected viral control at 3- and 6-mo postpartum.

12 y echocardiography at entry, 6 and 12 months postpartum.

13 ed between 12-20 wk of gestation and 0-14 wk postpartum.

14 d together with their infants until 24 weeks postpartum.

15 sults in a higher VDA of breast milk >/=2 mo postpartum.

16 D3, 25(OH)D2, and 25(OH)D3] at 2 wk and 2 mo postpartum.

17 is drugs already in use during pregnancy and postpartum.

18 n with the hormonal changes of pregnancy and postpartum.

19 their exclusively breastfed infants at 2 wk postpartum.

20 ly protective for maintaining mood stability postpartum.

21 sociated with less weight retention at 18 mo postpartum.

22 dual-energy X-ray absorptiometry (DXA) 2 wk postpartum.

23 tpartum and a 1.7-fold higher hazard at 6 mo postpartum.

24 inpatient or outpatient contacts 0-3 months postpartum.

25 African mother-infant pairs between 1-24 wk postpartum.

26 uch as STAT1, STAT2, and MAVS, were enriched postpartum.

27 s (n = 308) from pregnancy week 24 to 1 week postpartum.

28 risk subset for the development of active TB postpartum.

29 outcomes measured by survey at 2 to 4 weeks postpartum.

30 , and Nutrition study at 2 or 6 wk and 24 wk postpartum.

31 ected women are at risk of virologic failure postpartum.

32 nged from 91.9% at day 7 to 70.6% at month 6 postpartum.

33 ed (AOR, 2.60 [95% CI, 1.82-3.73]) at 1 year postpartum.

34 1.64% versus 14.29%, P = 0.0135) at 2 months postpartum.

35 d during pregnancy and were followed for 7 y postpartum.

36 tween 1995 and 2003 was followed for 8 years postpartum.

37 omen was 0.90 kg (IQR: -1.40, 3.25) at 18 mo postpartum.

38 the third trimester and continued until 6 mo postpartum.

39 No subtherapeutic levels were observed postpartum.

40 antitative HCV RNA at 3, 6, 9, and 12 months postpartum.

41 o postpartum or for 3 mo beginning at 0.5 mo postpartum.

42 egnant and postpartum patients up to 6 weeks postpartum.

43 LBW infants during 2 periods: from 0 to 5 mo postpartum (0-180 d postpartum) and from 6 to 12 mo post

44 into the following 4 groups from 6 to 12 mo postpartum: 1) no HS and no MNP (control), 2) HS only, 3

45 ly less likely to experience severe episodes postpartum (17%, 95% CI=13, 21) than patients with a his

46 tum (0-180 d postpartum) and from 6 to 12 mo postpartum (181-360 d postpartum) with the use of 48 clu

47 Most events occurred within the first month postpartum (35 of 50).

48 at birth; 12 mothers were lost to follow-up postpartum (5 iron, 7 placebo).

49 fants was lower than in term infants at 4 mo postpartum (8% compared with 19%).

50 ed solids in addition to breast milk at 4 mo postpartum achieved both standing [acceleration factor (

51 The rate of postpartum AD after second birth for women with no histo

52 uration of treatment, and rate of subsequent postpartum AD and other affective episodes in a nationwi

53 The recurrence risk of postpartum AD for women with a PPD hospital contact afte

54 their second birth compared to women with no postpartum AD history.

55 er second birth for women with no history of postpartum AD was 1.2 per 100 person-years.

56 Postpartum AD was defined as use of antidepressants and/

57 The recurrence risk of postpartum AD was markedly higher among women with PPD h

58 In this study, an episode of postpartum AD was observed for 0.6% of childbirths among

59 The main outcome measures were risk of postpartum AD, duration of treatment, and recurrence ris

60 h rate of later AD and recurrent episodes of postpartum AD.

61 this study was to estimate the incidence of postpartum affective disorder (AD), duration of treatmen

62 ia appears to occur frequently, particularly postpartum, among HIV-infected women after initial VS in

63 o P. falciparum and P. vivax antigens in 201 postpartum and 201 controls over 12 weeks.

64 6-fold higher hazard of stopping FAB at 3 mo postpartum and a 1.7-fold higher hazard at 6 mo postpart

65 testing, with repeat testing at delivery and postpartum and additional cytokines measured from the IG

66 h similar magnitudes of boosting observed in postpartum and control women.

67 expressing parasites did not rapidly decline postpartum and did not boost in response to infection in

68 id (IFA) during pregnancy and the first 3 mo postpartum and LNSs for the children from 6 to 24 mo (IF

69 1) LNSs during pregnancy and the first 6 mo postpartum and LNSs for the offspring from 6 to 24 mo (L

70 Dams were euthanized on d10 postpartum and mammary glands and duodenal tissue were h

71 evealed an additional water reservoir in the postpartum and multiparous cohorts pointing to redistrib

72 osis include lithium prophylaxis immediately postpartum and proactive safety monitoring.

73 each trimester of pregnancy and at 3 months postpartum and their children who underwent magnetic res

74 n of SQ-LNSs to women from pregnancy to 6 mo postpartum and to their infants from 6 to 18 mo of age m

75 periods: from 0 to 5 mo postpartum (0-180 d postpartum) and from 6 to 12 mo postpartum (181-360 d po

76 s across age groups in the exposed (pregnant/postpartum) and unexposed (nonpregnant) populations.

77 2, is elevated (e.g., lactating rats, 3-10 d postpartum), and (3) acute E2 administration would be su

78 first-onset psychiatric disorders 0-3 months postpartum, and 96 of these died during follow-up.

79 led, 48% were </=12 wk and 52% were 13-24 wk postpartum, and median maternal age was 25 y (interquart

80 mothers during pregnancy and the first 6 mo postpartum, and to children aged 6-18 mo, improves infan

81 intrapartum fever (0.4, 0.2-0.9), and use of postpartum antibiotics (0.8, 0.7-1.0), and longer hospit

82 as 55.4 per 100 person-years; for women with postpartum antidepressant medication after first birth,

83 act after first birth compared to women with postpartum antidepressant medication after first birth.

84 igher rate (95% CI 31.5-68.4) and women with postpartum antidepressant medication after their first b

85 Given that the neural systems affected by postpartum anxiety and depression overlap and interact w

86 maternal depressive symptoms prenatally and postpartum are associated with altered gray matter struc

87 f reasons for pumping between 1.5 and 4.5 mo postpartum are associated with HM-feeding durations.

88 2th and 30th weeks of pregnancy and 6 months postpartum as part of the Danish National Birth Cohort s

89 ntify women who were pregnant or </=12 weeks postpartum at time of SCAD.

90 ith GDM pregnancy were enrolled at 6-9 weeks postpartum (baseline) and were screened for T2D annually

91 at the time of Caesarian section to minimize postpartum blood loss and to further delineate the mass

92 Postpartum blues (PPB) is often a prodromal state for po

93 associations with maternal prepregnancy and postpartum BMI z scores and with paternal BMI z scores.

94 food insecurity was associated with adverse postpartum body-composition changes in Ugandan women.

95 Participants were thin at 1 wk postpartum [body mass index (BMI; in kg/m(2)): 22.9 +/-

96 rns about ART adherence during pregnancy and postpartum but few data on viral suppression (VS) over t

97 Patients with myocarditis (7.7%), postpartum cardiomyopathy (4.4%), and adriamycin-induced

98 hort studies of newborn cCMV screening in US postpartum care and early hearing programs.

99 IV self-tests to women seeking antenatal and postpartum care was successful in promoting partner test

100 accounted for in part by the development of postpartum chronic hypertension, hypercholesterolemia, t

101 None of the matched postpartum comparison subjects had confirmed neuronal su

102 tients with postpartum psychosis and matched postpartum comparison subjects.

103 m selenite was injected intraperitoneally on postpartum day 10, whereas N-acetylcysteine amide was in

104 taracts were evaluated at the end of week 2 (postpartum day 14) when the rat pups opened their eyes.

105 t reduces vulnerability to depressed mood at postpartum day 5, the typical peak of PPB.

106 rtum period, for example, the odds ratio for postpartum days 0-242 was 0.13 (95% CI=0.11, 0.16).

107 beginning on week 3 until the end of week 4 (postpartum days 15 to 30), and the rats were sacrificed

108 eine amide was injected intraperitoneally on postpartum days 9, 11, and 13 in the respective groups.

109 usly shown to be prospectively predictive of postpartum depression (PPD) when modeled in antenatal bl

110 Some 5%-15% of all women experience postpartum depression (PPD), which for many is their fir

111 m blues (PPB) is often a prodromal state for postpartum depression (PPD), with severe PPB strongly as

112 matter in children, though relations between postpartum depression and children's brains and the role

113 uch as that in autistic spectrum disorder or postpartum depression.

114 et of seven of 19 international sites in the Postpartum Depression: Action Towards Causes and Treatme

115 ion between preterm and CVD accounted for by postpartum development of CVD risk factors.

116 Compared with postpartum DXA values, Deming regressions revealed no su

117 rsus 14.29%, P = 0.0455), a lesser extent of postpartum elevations of ALT (P = 0.007), and a lower ra

118 Postpartum EPDS scores negatively correlated with childr

119 sivity, correlations survived correction for postpartum EPDS.

120 igher rate (95% CI 21.9-33.2) of a recurrent postpartum episode after their second birth compared to

121 We observed 4,550 (0.6%) postpartum episodes of AD.

122 ients with bipolar disorder and a history of postpartum episodes.

123 1 log10 between the third trimester and 3-mo postpartum exhibited HCV-specific T-cell responses of gr

124 uppression at delivery and during 4-8 weeks' postpartum follow-up.

125 d trimester, previous defaulting on ART, and postpartum follow-up.

126 cipants provided specimens through 12 months postpartum for batched viral load (VL) testing separate

127 his association persisted in the second year postpartum for both retention (AOR, 6.19 [95% CI, 4.04-9

128 d that the MC4R genotype was associated with postpartum glycemic changes; and the association with fa

129 to injectable uterotonics for management of postpartum haemorrhage remains limited in Senegal outsid

130 Postpartum haemorrhage was diagnosed in one woman alloca

131 vious study of misoprostol for prevention of postpartum haemorrhage were excluded to prevent contamin

132 propriate for community-level prophylaxis of postpartum haemorrhage.

133 Here, we demonstrated that postpartum HCV control was associated with enhanced viru

134 erall incidence of spontaneous abortions and postpartum hemorrhage of 19.8% and 21.4%, respectively.

135 cal settings such as cardiovascular surgery, postpartum hemorrhage, and trauma.

136 No significant differences were found in postpartum hemorrhage, cesarean section, and elevated cr

137 Postpartum hepatitis C viral (HCV) load decline followed

138 wth factor was independently associated with postpartum hypertension (de novo hypertensive group: odd

139 From pregnancy until 12 months postpartum, IL28B-CC allele women had a significant vira

140 nd periodontal changes in pregnant women and postpartum in the absence of periodontal treatment, and

141 anges in their HPA axis during pregnancy and postpartum, including assessment of maternal-specific st

142 ariant rs6567160 was associated with greater postpartum increase of HbA1c (beta = 0.08%; P = 0.03) an

143 motor development at 4, 8, 12, 18, and 24 mo postpartum; information on infant feeding was reported a

144 -effective, and vaccination of either parent postpartum is strongly dominated by antepartum maternal

145 absolute VTE risk is above a threshold where postpartum LMWH prophylaxis should be considered (4.4%;

146 to women during pregnancy and the first 6 mo postpartum, LNSs provided to their offspring from 6 to 2

147 ns is necessary for the normal expression of postpartum maternal behavior in mice.

148 The differences in postpartum mean weight gain persisted over the 8-year st

149 At 8 wk postpartum, mean [nmol/L (95% CI)] infant 25(OH)D at 8 w

150 requency of P-SCAD occurred during the first postpartum month and P-SCAD patients less often had extr

151 an milk oligosaccharides (HMOs) from 6-month-postpartum mothers in two Malawian birth cohorts reveale

152 cts of caregiving in this urban sample of 76 postpartum mothers.

153 From pregnancy to 36 months postpartum, mothers in the intervention group had signif

154 samples collected at approximately 3 months postpartum (n = 56 women).

155 cross the placenta to the fetus, leading to postpartum neonatal abstinence syndrome.

156 t cry during fMRI, we tested hypotheses that postpartum neural response to the cry of "own" versus a

157 higher MRR (3.74; 95% CI=3.06-4.57) than non-postpartum-onset mothers (MRR=2.73; 95% CI=2.67-2.79) wh

158 not boost in response to infection in either postpartum or control women.

159 es for 1 mo beginning at 0.5, 1.5, or 2.5 mo postpartum or for 3 mo beginning at 0.5 mo postpartum.

160 changes continue to affect humoral immunity postpartum or how quickly they resolve.

161 ic T-cell immunity and viral control at 3-mo postpartum (P = 0.0002).

162 n (n = 797), these included all pregnant and postpartum patients up to 6 weeks postpartum.

163 ted causes during pregnancy or up to 42 days postpartum per 100,000 live births) or neonatal mortalit

164 issection or rupture during the pregnancy or postpartum period and 9 cases during the control period

165 nal weight from before pregnancy through the postpartum period and assessed the relations between mat

166 maternal interviews during pregnancy and the postpartum period and from a 7-y follow-up.

167 anges of the cornea during pregnancy and the postpartum period and its association to hormonal change

168 d depression symptoms were higher during the postpartum period and were associated with adverse socia

169 sk of acute appendicitis was observed in the postpartum period compared with the time outside pregnan

170 ey do have unique neural profiles during the postpartum period compared with when they occur at other

171 linum antitoxin use during pregnancy and the postpartum period have not been systematically reviewed.

172 The postpartum period is associated with a high risk of psyc

173 Hypertension in the postpartum period is relatively common and is associated

174 ophysiology of hypertension in the immediate postpartum period is unclear.

175 Exposures: Pregnancy, including the postpartum period up to 6 weeks after delivery.

176 iation recommends T2D screening in the early postpartum period via oral glucose tolerance testing aft

177 n the third trimester) and 1 case during the postpartum period were identified.

178 ith breast cancer during pregnancy or in the postpartum period with that of women who had breast canc

179 .001), were diagnosed with PPCM later in the postpartum period, and were more likely to present with

180 linum antitoxin use during pregnancy and the postpartum period, as well as the Centers for Disease Co

181 g abuse is also substantially reduced in the postpartum period, for example, the odds ratio for postp

182 er million patients during pregnancy and the postpartum period, in comparison with 1.4 (95% confidenc

183 ed women in this cohort presented during the postpartum period.

184 f women during pregnancy or in the immediate postpartum period.

185 ies, including women during the pregnant and postpartum period.

186 lations appear to be uniquely related to the postpartum period.

187 rupture is elevated during pregnancy and the postpartum period.

188 h first-onset affective psychosis during the postpartum period.

189 tive effects may be present in the immediate postpartum period.

190 and those with sufficiency during the early postpartum period; however, the values of thyrotropin in

191 spectively followed during pregnancy and the postpartum period; obstetric, labor, delivery, and pedia

192 y (OR 10.5, 95% CI 3.6-30.5) and of enduring postpartum physical problems linked to perineal trauma d

193 (IFA) provided to women during pregnancy and postpartum plus micronutrient powder (MNP) or no supplem

194 ored infant facial expressions at two months postpartum predicted infant motor system activity during

195 d virgin, multiparous, two- and fourteen-day postpartum primiparous rats.

196 e risk of AD flares, genital infections, and postpartum problems related to perineal trauma.

197 Postpartum progesterone and CRP declined sharply from 90

198 Women with postpartum psychiatric disorders had a higher MRR (3.74;

199 Women with severe postpartum psychiatric disorders had increased MRRs comp

200 esented 40.6% of fatalities among women with postpartum psychiatric disorders, and within the first y

201 subsequent pregnancy for women with isolated postpartum psychoses is 31% (95% CI=22-42).

202 % CI=13, 21) than patients with a history of postpartum psychosis (29%, 95% CI=20, 41).

203 Ninety-six consecutive patients with postpartum psychosis and 64 healthy postpartum women wer

204 ntibodies in a large cohort of patients with postpartum psychosis and matched postpartum comparison s

205 es of remission in patients with first-onset postpartum psychosis and that lithium maintenance may be

206 Strategies for prevention of postpartum psychosis include lithium prophylaxis immedia

207 Postpartum psychosis offers an intriguing model to explo

208 ed with bipolar disorder and/or a history of postpartum psychosis or mania according to DSM or ICD cr

209 In women with a history of isolated postpartum psychosis, initiation of prophylaxis immediat

210 Women with a history of bipolar disorder, postpartum psychosis, or both are at high risk for postp

211 ient episode, 20%-50% of women have isolated postpartum psychosis.

212 ublications have focused on the treatment of postpartum psychosis.

213 The incidence of first-lifetime onset postpartum psychosis/mania from population-based registe

214 of predominant breastfeeding during 6 months postpartum ranged from 91.9% at day 7 to 70.6% at month

215 Studies were included if they reported postpartum relapse in patients diagnosed with bipolar di

216 is meta-analysis was to estimate the risk of postpartum relapse in these three patient groups.

217 In women with bipolar disorder, postpartum relapse rates were significantly higher among

218 The overall postpartum relapse risk was 35% (95% CI=29, 41).

219 One-third of women at high risk experience a postpartum relapse.

220 rtum psychosis, or both are at high risk for postpartum relapse.

221 ast one volunteer visit during pregnancy and postpartum, respectively.

222 lysis of the 3 trials that measured maternal postpartum smoking relapse prevention demonstrated a sig

223 on, parental smoking reduction, and maternal postpartum smoking relapse prevention.

224 ecent interpersonal violence, pre- and early postpartum stress, gestational age at birth, infant sex,

225 nd single-dose nevirapine plus a 1-to-2-week postpartum "tail" of tenofovir and emtricitabine (zidovu

226 Five developed postpartum TB, of which three had IGRA(+)/TST(-) discord

227 dence interval, 33%-98%) more effective than postpartum Tdap vaccination at preventing pertussis in i

228 Bacterial load was greater at seven days postpartum than at dry off.

229 = 0.0052) and magnitude (P = 0.026) at 3-mo postpartum than women who failed to control viremia.

230 Postpartum, the absolute VTE risk is above a threshold w

231 nza-like illness in pregnancy and 0-180 days postpartum, the incidence of low birthweight (<2500 g),

232 Together, these data suggest that postpartum, the normalization of the physiological rheos

233 he first antenatal clinic visit and at 18 mo postpartum.The median retained weight of women was 0.90

234 Postpartum, there was a dramatic reduction in progestero

235 of patients, but not on virtually all normal postpartum tissues.

236 ox proportional hazard models (from 12 weeks postpartum to March 2012).

237 intrapartum haemorrhage, intrapartum fever, postpartum treatment with antibiotics, and mode of deliv

238 logic and genetic research and physiological postpartum triggers (endocrine, immunological, circadian

239 IL28B-CC genotype and 12-month postpartum undetectable viremia were the best predictors

240 weeks gestation was 85% more effective than postpartum vaccination at preventing pertussis in infant

241 Nonetheless, postpartum vaccination of mothers who were not vaccinate

242 al and ethnic effects upon the pregnancy and postpartum vaginal microbiome and has important implicat

243 Postpartum viral control was associated with the IFNL3 r

244 examined at 2 visits during pregnancy and 2 postpartum visits within 12 weeks.

245 flavors in mothers' milk, starting at 0.5 mo postpartum, was sufficient to shift the hedonic tone, wh

246 samples were obtained from Kenyan mothers at postpartum weeks 6, 10, 14, and 18 and analyzed for pres

247 ifies the relationship between lactation and postpartum weight gain, makes an important contribution

248 ous efficacy trial has successfully produced postpartum weight loss; however, the effectiveness of th

249 may offer an alternative strategy to assist postpartum weight reduction by increasing EPA and DHA st

250 sting glucose were significantly modified by postpartum weight reduction in women who had experienced

251 an interaction between the MC4R genotype and postpartum weight reduction on changes in fasting plasma

252 The MC4R genotype, postpartum weight reduction, and glycemic changes betwee

253 ational weight gain (GWG) is associated with postpartum weight retention (PPWR) and abdominal adiposi

254 aternal plasma PUFAs in pregnancy with 18-mo postpartum weight retention (PPWR) in a multiethnic Asia

255 Postpartum weight retention increases lifetime risk of o

256 (in kg/m(2))], gestational weight gain, and postpartum weight retention may have distinct effects on

257 epregnancy BMI, gestational weight gain, and postpartum weight retention to create maternal weight tr

258 uence than either gestational weight gain or postpartum weight retention.

259 ng an association of lactation with maternal postpartum weight status and dyslipidemia, whereas more

260 Maternal age, time postpartum, weight, and body mass index were all correla

261 Geometric mean ratios of third trimester vs postpartum were 0.55 (90% confidence interval [CI], .46-

262 Breast milk samples obtained at 3 months postpartum were analyzed for PBDEs.

263 n mother/infant pairs at 4, 16, and 20 weeks postpartum were analyzed for relationships between HMOs,

264 t 12-20 wk of gestation and again at 0-14 wk postpartum were included in this analysis.

265 index (BMI; in kg/m(2)) of >/=27 at 6-15 wk postpartum were randomly assigned to the diet behavior m

266 m) and from 6 to 12 mo postpartum (181-360 d postpartum) with the use of 48 clusters.

267 Among pregnant and postpartum women 18 years and older, 6 trials (n = 11,86

268 Six hundred antenatal and postpartum women aged 18-39 y were randomized to an HIV

269 Postpartum women are at increased risk of developing pue

270 or-blind, clinical trial enrolling 371 adult postpartum women at 12 clinics in WIC programs from the

271 dy levels, and whether this was different in postpartum women compared with control women.

272 risk of stroke by age group in pregnant and postpartum women compared with their nonpregnant contemp

273 s, and Children (WIC program) for low-income postpartum women could produce greater weight loss than

274 Ten to twenty percent of postpartum women experience anxiety or depressive disord

275 idence suggested that screening pregnant and postpartum women for depression may reduce depressive sy

276 ding multiple HIV self-tests to pregnant and postpartum women for secondary distribution is more effe

277 r review of 17 cases of botulism in pregnant/postpartum women found that more than half required vent

278 Postpartum women had reduced Plasmodium spp. antibody le

279 pective study of incident HIV among pregnant/postpartum women in Kenya were randomly divided into der

280 sting and couples testing among pregnant and postpartum women in sub-Saharan Africa is essential for

281 To advance inclusion of pregnant and postpartum women in tuberculosis drug trials, the US Nat

282 Over 12 weeks, mean antibody levels in postpartum women increased to levels observed in control

283 ser but was consistent with the evidence for postpartum women regarding the benefits of screening, th

284 ulative incidence of PAS per 100000 pregnant/postpartum women vs nonpregnancy-associated stroke (NPAS

285 o 24 years was 14 events per 100000 pregnant/postpartum women vs NPAS incidence of 6.4 per 100000 non

286 nts with postpartum psychosis and 64 healthy postpartum women were included.

287 ally relevant and sustainable weight loss in postpartum women with overweight and obesity.

288 ults for the benefit of CBT for pregnant and postpartum women with screen-detected depression showed

289 fication treatment to produce weight loss in postpartum women within the primary health care setting

290 Controls were randomly selected postpartum women without VTE, matched on birth year.

291 Among low-income postpartum women, an internet-based weight loss program

292 cases of invasive GBS disease in pregnant or postpartum women, and 57000 (UR, 12000-104000) fetal inf

293 , including invasive disease in pregnant and postpartum women, fetal infection/stillbirth, and infant

294 ession, including depression in pregnant and postpartum women.

295 or viral decline in a cohort of HCV-infected postpartum women.

296 ired ability to mount a boosting response in postpartum women.

297 ral adult population, including pregnant and postpartum women.

298 ive behavioral therapy (CBT) in pregnant and postpartum women.

299 ons, including older adults and pregnant and postpartum women; the accuracy of depression screening i

300 Two to four weeks postpartum, women completed a 91-item survey by telephon